Latest Investment Markets News

Light & Wonder unveiled ambitious growth targets and strategic plans at its 2025 Investor Day, spotlighting strong financial momentum and the integration of Grover Charitable Gaming. The company aims for $1.4 billion consolidated AEBITDA in 2025, underpinned by robust R&D and market leadership.

ARC Funds Limited has acquired a controlling interest in The Term Deposit Shop, bolstering its position in the online cash investment space while raising $600,000 in equity and $800,000 in debt financing.

Anagenics Limited reported a cash outflow of $424K for Q3 2025 but maintains robust liquidity with $1.48 million in available funding, supported by a mix of secured and unsecured loans.

Baby Bunting reports a 2.9% year-to-date comparable store sales growth and opens an innovative new store format in Melbourne, raising its FY25 NPAT guidance amid strong early results.

Desane Group Holdings has secured a seven-year lease extension with Signature Orthopaedics at its Lane Cove property, guaranteeing $5 million in rental income through 2032. This deal reinforces Desane’s strategy to maintain stable medium-term cash flows.

Boss Energy’s March quarter report reveals a successful ramp-up at its Honeymoon Uranium Project, delivering its first free cash flow and beating cost guidance, while strategic investments and exploration progress position the company well amid a tightening uranium market.

GWR is actively pursuing transformative project acquisitions across global jurisdictions while trading significantly below its cash and investment backing. The company’s robust cash position and critical minerals investments position it well amid shifting global supply dynamics.

Charter Hall Retail REIT reports solid 1H FY25 results with $73.1 million operating earnings and strategic moves to enhance income growth, including a major stake in Hotel Property Investments Ltd.

Unibail-Rodamco-Westfield delivered robust FY-2024 results with a 7% rise in like-for-like EBITDA and adjusted recurring EPS surpassing guidance, supported by strong retail and convention business performance. The company also announced a 40% increase in its proposed dividend, reflecting confidence in its financial health and strategic asset management.

IMDEX Limited has announced a fully franked ordinary dividend of AUD 0.015 per share, signaling steady shareholder returns for the half-year ending December 2024.

Paradigm Biopharmaceuticals has launched a Loyalty and Piggyback Options program aimed at rewarding shareholders and raising up to $111.96 million to support its pivotal Phase III clinical trial.

Fitzroy River Corporation's latest quarterly report reveals a dip in royalty income but highlights progress on major silver and gold projects, alongside strategic moves in energy royalties.